Bristol Myers Squibb Named One of America’s Most JUST Companies by JUST Capital and CNBC
06 February 2024 - 1:00AM
Business Wire
Bristol Myers Squibb Company ranks in top 10
of Pharmaceutical and Biotech Sector on the issues Americans care
about most
Bristol Myers Squibb (NYSE: BMY) is honored to announce it has
been recognized as One of America's Most JUST Companies. The
ranking, presented by JUST Capital and CNBC, recognized BMS for its
commitment to key social responsibilities, including employees,
customers, communities, and environmental impact. Bristol Myers
Squibb earned a spot on the top 100 list and ranked six in the
Pharmaceuticals and Biotech industry overall.
This achievement is reflective of BMS’ focus on delivering
long-term value through our efforts to address unmet patient needs,
advance equitable access to life-transforming medicines and foster
a high performing, inclusive global workforce. It also underscores
our commitment to operating with effective governance,
uncompromising quality and compliance, and the highest ethical
standards to deliver our mission.
“We are proud to be recognized as a leader by JUST 100,
reinforcing our focus on community impact, employee well-being and
ethical practices to best serve our patients,” said Cari Gallman,
Executive Vice President, Bristol Myers Squibb. “This achievement
reflects our collective passion for excellence in what we do– not
only by bringing forward innovative medicines, but also by making a
positive impact on society.”
Out of nearly 1,000 analyzed companies, BMS’ leadership on
community issues, particularly job creation and economic
development, contributed to its inclusion in this prestigious
ranking. Among the notable achievements are BMS’ efforts to invest
more than one billion dollars with small and diverse-owned
businesses, creating economic opportunities in underrepresented
communities.
Additionally, BMS was recognized for its ethical interactions
with stakeholders, noting efforts to protect customer privacy,
which are guided by the company’s Principles of Integrity and
Standards of Business Conduct and Ethics.
Learn more about Bristol Myers Squibb’s ESG progress and
sustainability commitments in the latest Environmental Social and
Governance Report.
About JUST Capital The mission of JUST Capital, an
independent nonprofit, is to demonstrate how just business –
defined by the priorities of the public – is better business. Our
goal is to help companies create value for all their stakeholders –
their workers, customers, communities, the environment, and
shareholders – by focusing on the issues that matter most to
Americans.
For the annual Rankings, JUST Capital collects and analyzes
corporate data to evaluate the 1,000 largest public U.S. companies
across 20 Issues identified through comprehensive, ongoing public
opinion research on Americans’ attitudes toward responsible
corporate behavior. JUST Capital has engaged more than 170,000
participants, on a fully representative basis, since 2015.
CNBC will delve into the data, highlighting company-specific
results and showcasing key stakeholder performance stories about
this year’s JUST 100 leaders across the network’s broadcast and
digital platforms at cnbc.com/just100. An exploration of the JUST
100 companies can be found at justcapital.com/rankings.
About Bristol Myers Squibb Bristol Myers Squibb is
a global biopharmaceutical company whose mission is to discover,
develop and deliver innovative medicines that help patients prevail
over serious diseases. For more information about Bristol Myers
Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter,
YouTube, Facebook, and Instagram.
corporatefinancial-news
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240205190223/en/
Bristol Myers Squibb Media Inquiries: media@bms.com
Bristol Myers Squibb (NYSE:BMY)
Historical Stock Chart
From Apr 2024 to May 2024
Bristol Myers Squibb (NYSE:BMY)
Historical Stock Chart
From May 2023 to May 2024